Cargando…

Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis

BACKGROUND AND OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%–10% of all ALS cases; however, no recent literature review or meta-analysis of this proportion (referred to throughout as “proportion fALS”...

Descripción completa

Detalles Bibliográficos
Autores principales: Barberio, Julie, Lally, Cathy, Kupelian, Varant, Hardiman, Orla, Flanders, W. Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689005/
https://www.ncbi.nlm.nih.gov/pubmed/38045991
http://dx.doi.org/10.1212/NXG.0000000000200109
_version_ 1785152278297051136
author Barberio, Julie
Lally, Cathy
Kupelian, Varant
Hardiman, Orla
Flanders, W. Dana
author_facet Barberio, Julie
Lally, Cathy
Kupelian, Varant
Hardiman, Orla
Flanders, W. Dana
author_sort Barberio, Julie
collection PubMed
description BACKGROUND AND OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%–10% of all ALS cases; however, no recent literature review or meta-analysis of this proportion (referred to throughout as “proportion fALS”) has been conducted. Our objective was to estimate the proportion fALS by geographic region and to assess the effect of study characteristics on the estimates. METHODS: A comprehensive literature review was performed to identify all original studies reporting the number of fALS cases in an ALS cohort. The results were stratified by geographic region, study design (case series or population-based), and decade of study publication. Subgroup analyses were conducted according to family history criteria used to define fALS. We report pooled estimates of the proportion fALS from random-effects meta-analyses when >2 studies are available and I(2) is < 90%; weighted averages and ranges are otherwise presented. RESULTS: The overall pooled proportion fALS based on a total 165 studies was 8% (0%, 71%). The proportion fALS was 9% (0%, 71%) among 107 case series and 5% (4%, 6%) among 58 population-based studies. Among population-based studies, proportion fALS by geographic region was 6% (5%, 7%; N = 37) for Europe, 5% (3%, 7%; N = 5) for Latin America, and 5% (4%, 7%; N = 12) for North America. Criteria used to define fALS were reported by 21 population-based studies (36%), and proportion fALS was 5% (4%, 5%; N = 9) for first-degree relative, 7% (4%, 11%; N = 4) for first or second-degree relative, and 11% (N = 1) for more distant ALS family history. Population-based studies published in the 2000s or earlier generated a lower pooled proportion fALS than studies published in the 2010s or later. DISCUSSION: The results suggest that variability in the reported proportion fALS in the literature may be, in part, due to the differences in geography, study design, fALS definition, and decade of case ascertainment. Few studies outside of European ancestral populations were available. The proportion fALS was marginally higher among case series compared with population-based studies, likely because of referral bias. Criteria used to define fALS were largely unreported. Consensus criteria for fALS and additional population-based studies in non-European ancestral populations are needed.
format Online
Article
Text
id pubmed-10689005
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-106890052023-12-01 Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis Barberio, Julie Lally, Cathy Kupelian, Varant Hardiman, Orla Flanders, W. Dana Neurol Genet Research Article BACKGROUND AND OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%–10% of all ALS cases; however, no recent literature review or meta-analysis of this proportion (referred to throughout as “proportion fALS”) has been conducted. Our objective was to estimate the proportion fALS by geographic region and to assess the effect of study characteristics on the estimates. METHODS: A comprehensive literature review was performed to identify all original studies reporting the number of fALS cases in an ALS cohort. The results were stratified by geographic region, study design (case series or population-based), and decade of study publication. Subgroup analyses were conducted according to family history criteria used to define fALS. We report pooled estimates of the proportion fALS from random-effects meta-analyses when >2 studies are available and I(2) is < 90%; weighted averages and ranges are otherwise presented. RESULTS: The overall pooled proportion fALS based on a total 165 studies was 8% (0%, 71%). The proportion fALS was 9% (0%, 71%) among 107 case series and 5% (4%, 6%) among 58 population-based studies. Among population-based studies, proportion fALS by geographic region was 6% (5%, 7%; N = 37) for Europe, 5% (3%, 7%; N = 5) for Latin America, and 5% (4%, 7%; N = 12) for North America. Criteria used to define fALS were reported by 21 population-based studies (36%), and proportion fALS was 5% (4%, 5%; N = 9) for first-degree relative, 7% (4%, 11%; N = 4) for first or second-degree relative, and 11% (N = 1) for more distant ALS family history. Population-based studies published in the 2000s or earlier generated a lower pooled proportion fALS than studies published in the 2010s or later. DISCUSSION: The results suggest that variability in the reported proportion fALS in the literature may be, in part, due to the differences in geography, study design, fALS definition, and decade of case ascertainment. Few studies outside of European ancestral populations were available. The proportion fALS was marginally higher among case series compared with population-based studies, likely because of referral bias. Criteria used to define fALS were largely unreported. Consensus criteria for fALS and additional population-based studies in non-European ancestral populations are needed. Wolters Kluwer 2023-11-30 /pmc/articles/PMC10689005/ /pubmed/38045991 http://dx.doi.org/10.1212/NXG.0000000000200109 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Barberio, Julie
Lally, Cathy
Kupelian, Varant
Hardiman, Orla
Flanders, W. Dana
Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title_full Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title_fullStr Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title_full_unstemmed Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title_short Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
title_sort estimated familial amyotrophic lateral sclerosis proportion: a literature review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689005/
https://www.ncbi.nlm.nih.gov/pubmed/38045991
http://dx.doi.org/10.1212/NXG.0000000000200109
work_keys_str_mv AT barberiojulie estimatedfamilialamyotrophiclateralsclerosisproportionaliteraturereviewandmetaanalysis
AT lallycathy estimatedfamilialamyotrophiclateralsclerosisproportionaliteraturereviewandmetaanalysis
AT kupelianvarant estimatedfamilialamyotrophiclateralsclerosisproportionaliteraturereviewandmetaanalysis
AT hardimanorla estimatedfamilialamyotrophiclateralsclerosisproportionaliteraturereviewandmetaanalysis
AT flanderswdana estimatedfamilialamyotrophiclateralsclerosisproportionaliteraturereviewandmetaanalysis